Clinical trial
Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous…
NCT00004747 · National Center for Research Resources (NCRR), NIH · Completed
Key facts
| NCT number | NCT00004747 |
|---|---|
| Title | Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Vanderbilt University Medical Center |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis, Bacterial Infections |
| Intervention type | Drug |
| Interventions | mucoid exopolysaccharide P. aeruginosa immune globulin IV |
| Enrollment | 170 |
| Start date | Jul 1, 1995 |
| First posted | Feb 25, 2000 |
| Last update posted | Jun 24, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: